Document is current
Any future updates will be listed below
-
Authors
Stubbs, Caleb K.
Biancucci, Marco
Vidimar, Vania
Satchell, Karla J. F.
-
Funding
Funding for this research was provided by:
National Cancer Institute (T32CA09560)
Chicago Biomedical Consortium
H Foundation
Northwestern Medicine Catalyst Fund
- License Information
-
More Information
Article History
Received: 22 April 2021
Accepted: 24 August 2021
First Online: 9 September 2021
Competing interests
: K.J.F.S. has been granted a patent (US 10,829,752 B2) on use of RRSP to treat cancer. K.J.F.S. is a consultant for Buoy Health on topics unrelated to this manuscript. K.J.F.S. has a significant financial interest in Situ Biosciences, LLC, a contract research organization that pursues research unrelated to cancer. C.K.S. is an intern as a scientific and financial advisor for Aspire Capital Partners, LLC, which invests in oncotherapies. All other authors declare no conflicts of interest.
